Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.
Alto Crescimento de Lucro
O lucro líquido da empresa lidera o setor, com o lucro anual mais recente totalizando US$ 1.08B.
Alto Dividendo
A empresa é uma grande pagadora de dividendos, com índice de distribuição mais recente de 38.36%.
Subavaliada
O PE mais recente da empresa é 1.75, em uma faixa percentil baixa de 3 anos.
Venda Institucional
As participações institucionais mais recentes são de 59.40M ações, uma redução de 7.24% em relação ao trimestre anterior.
Mantido por Donald Yacktman
O Super Investidor Donald Yacktman possui 9.87M ações desta empresa.